2Hang TJ. DNA vaccine and viral hepatitis :are we going around in circles [J] .Gastroenterology, 1997,112(4) : 1410-1414.
3Takahashi H, Nakagawa Y, Pendleton CD, et al. Induction of broadly cross-reactive cytotoxic T-cells recognizing an HIV-1 envelope determinant [J] .Science, 1992,255(1) :333-336.
4Shirai M, Akatsuka T, Pendleton CD, et al. Induction of cytotoxic T cells to cross reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein [J] .J Virol, 1992,66(7) :4098-4106.
5Triyatui M ,Jilbert AR, Qiao M, et al. Protective efficacy of DNA vaccinnes against duck hepatitis B virus infection [ J]. J Virol, 1998, 72(1) 84-94.
6Kuhroker A, Wild J, PudoUck HP, et a2. DNA vaccination with plasmid encoding the intracellular (HBcAg) or secrected (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping kb-and kd-restricted epitopes [ J ]. Int Immunol, 1997,9 ( 8 ) :1203-1212.
7Salleberg M, Hughes J, Javadian A, et al. Genetic immunization of champanzees chronically infected with the hepatitia B virus, using a recombinant retrovirus vector enconding the hepatitis B virus core antigen [J]. Hum Gene Ther, 1998,9(12) : 1719-1729.
8Le Borgne S, Mancini M, Le Gand R, et al. In vivo induction of specific cytotoxic T lymphocytes in mice or rhesus macaquesd immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen [J]. Virology, 1998,240(2) :304-315.
9Major ME. DNA-based immunization with chimeric vector for induction of immune responses against the hepatitis C virus nucleocapsid [ J ]. J Virol, 1995,69(9) :5798-5805.
10Kwissa M, Unsinger J, Schirmbeck R, et al. Polyvalent DNA vaccine with bidirectional promoter [J] .J Mol Med,2000,78(9):495-506.
